Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward standardized care: International expert survey on pregnancy management in long-chain fatty acid oxidation disorders and unmet needs.

Molecular genetics and metabolism·2026
Same author

Pregnancies in Women With Long-Chain Fatty Acid Oxidation Disorders: Results of a European and North American Survey.

Journal of inherited metabolic disease·2026
Same author

Transforming Growth Factor-β-Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria-Identification of a New Therapeutic Target.

Journal of inherited metabolic disease·2025
Same author

Pitfalls in the diagnosis of carnitine palmitoyltransferase 1 deficiency.

Journal of pediatric endocrinology & metabolism : JPEM·2025
Same author

A Noncatalytic Cysteine Residue Modulates Cobalamin Reactivity in the Human B<sub>12</sub> Processing Enzyme CblC.

Biochemistry·2025
Same author

The cobalamin processing enzyme of Trichoplax adhaerens.

The Journal of biological chemistry·2024

Related Experiment Video

Updated: Jun 12, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Ute Spiekerkoetter1, Philip A Wood

  • 1Department of General Pediatrics, University Children's Hospital, Duesseldorf, Germany. ute.spiekerkoetter@uni-duesseldorf.de

Journal of Inherited Metabolic Disease
|June 10, 2010
PubMed
Summary

Mouse models reveal diverse mechanisms in fatty acid oxidation defects, impacting energy, glucose, and fetal development. Understanding these pathways is key to developing targeted therapies for these disorders.

More Related Videos

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Area of Science:

  • Biochemistry
  • Genetics
  • Pathophysiology

Background:

  • Fatty acid oxidation defects encompass a range of genetic disorders affecting cellular energy metabolism.
  • Mouse models are crucial for elucidating the complex pathogenetic mechanisms underlying these conditions.

Purpose of the Study:

  • To investigate the diverse pathogenetic mechanisms and pathophysiology of fatty acid oxidation defects using mouse models.
  • To explore the role of these defects in conditions such as cardiomyopathy, myopathy, hypoglycemia, and intrauterine complications.

Main Methods:

  • Utilizing genetically engineered mouse models deficient in specific fatty acid oxidation enzymes (e.g., VLCAD, MCAD, LCHAD).
  • Analyzing tissue carnitine levels, acylcarnitine production, energy metabolism, glucose homeostasis, and embryonic development.

Main Results:

  • L-carnitine supplementation can induce potentially toxic acylcarnitine production in very-long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
  • Energy deficiency is a significant factor in cardiomyopathy, skeletal myopathy, and cold intolerance.
  • Hypoglycemia results from altered hepatic glucose output and peripheral glucose uptake, not solely transcriptional changes, in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice.
  • Impaired fatty acid oxidation may contribute to embryonic loss and is linked to HELLP syndrome in pregnancies with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD)-deficient fetuses.
  • Synergistic heterozygosity influences clinical phenotypes and severity in fatty acid oxidation disorders.

Conclusions:

  • Mouse models provide critical insights into the varied pathogenetic mechanisms of fatty acid oxidation defects.
  • Understanding these mechanisms is essential for developing specific and effective therapeutic strategies.